A detailed history of Sjs Investment Consulting Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 4 shares of VCYT stock, worth $158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 4 -0.0%
Holding current value
$158
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$18.86 - $23.55 $18 - $23
-1 Reduced 20.0%
4 $0
Q1 2024

Apr 18, 2024

BUY
$21.0 - $29.1 $42 - $58
2 Added 66.67%
5 $0
Q4 2023

Jan 16, 2024

SELL
$19.72 - $28.68 $19 - $28
-1 Reduced 25.0%
3 $0
Q3 2023

Oct 17, 2023

SELL
$22.33 - $29.92 $22 - $29
-1 Reduced 20.0%
4 $0
Q2 2023

Jul 13, 2023

BUY
$20.96 - $26.99 $83 - $107
4 Added 400.0%
5 $0
Q1 2023

Apr 20, 2023

BUY
$20.58 - $27.89 $20 - $27
1 New
1 $0

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.83B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Sjs Investment Consulting Inc. Portfolio

Follow Sjs Investment Consulting Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sjs Investment Consulting Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sjs Investment Consulting Inc. with notifications on news.